捷安高科(300845.SZ):北京嘉景持股比例變動達1.0093%
格隆匯7月25日丨捷安高科(300845.SZ)公佈,持股5%以上股東北京嘉景投資管理中心(有限合夥)(簡稱“北京嘉景”)自2023年3月15日至2023年3月24日以集中競價的方式合計減持1,091,800股,佔減持時總股本0.9851%。截至2023年7月25日,公司因股權激勵計劃實施增加480,726股,公司股份總數增至111,307,926股,受此影響,北京嘉景持股比例被動稀釋減少0.0242%。綜上,北京嘉景因前次減持及股權激勵計劃實施導致被動稀釋原因,其持股比例變動合計超過1%,達1.0093%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.